Saqib Islam

Insider Reports History

Location
Alexion Pharmaceuticals, 352 Knotter Drive, Cheshire, CT
Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Saqib Islam:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SpringWorks Therapeutics, Inc. Chief Executive Officer, Director Common Stock 0 $0 $46.20 Jul 1, 2025 Direct
Passage BIO, Inc. Director Director Stock Option (right to buy) 202K May 28, 2025 Direct
ARS Pharmaceuticals, Inc. Director Stock Option (right to buy) 30K Jun 25, 2025 Direct
SpringWorks Therapeutics, Inc. Chief Executive Officer, Director Performance Share Units 0 Jul 1, 2025 Direct
SpringWorks Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 0 Jul 1, 2025 Direct

Insider Reports Filed by Saqib Islam

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SWTX SpringWorks Therapeutics, Inc. Jul 1, 2025 9 $0 4 Jul 2, 2025 Chief Executive Officer, Director
SPRY ARS Pharmaceuticals, Inc. Jun 25, 2025 1 $0 4 Jun 27, 2025 Director
PASG Passage BIO, Inc. May 28, 2025 1 $0 4 May 30, 2025 Director
SWTX SpringWorks Therapeutics, Inc. Feb 27, 2025 6 -$4.3M 4 Mar 5, 2025 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Feb 20, 2025 2 -$1.77M 4 Feb 24, 2025 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Feb 14, 2025 1 -$639K 4 Feb 19, 2025 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Feb 12, 2025 2 -$782K 4 Feb 14, 2025 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Feb 10, 2025 1 -$2.56M 4 Feb 12, 2025 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Jan 10, 2025 2 $0 4 Jan 14, 2025 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Jan 4, 2025 3 -$1.49M 4 Jan 7, 2025 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Dec 2, 2024 2 -$2.03M 4 Dec 4, 2024 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Sep 3, 2024 3 -$1.99M 4 Sep 4, 2024 Chief Executive Officer, Director
SPRY ARS Pharmaceuticals, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
SWTX SpringWorks Therapeutics, Inc. Jun 3, 2024 4 -$1.96M 4 Jun 5, 2024 Chief Executive Officer, Director
PASG Passage BIO, Inc. May 21, 2024 1 $0 4 May 23, 2024 Director
SWTX SpringWorks Therapeutics, Inc. Jan 4, 2024 4 -$1.23M 4 Jan 8, 2024 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Nov 30, 2023 1 $0 4 Dec 1, 2023 Chief Executive Officer, Director
SPRY ARS Pharmaceuticals, Inc. Jun 27, 2023 1 $0 4 Jun 28, 2023 Director
PASG Passage BIO, Inc. May 25, 2023 1 $0 4 May 26, 2023 Director
SWTX SpringWorks Therapeutics, Inc. Jan 7, 2023 1 -$108K 4 Jan 10, 2023 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Jan 5, 2023 3 -$231K 4 Jan 9, 2023 Chief Executive Officer, Director
SPRY Silverback Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
PASG Passage BIO, Inc. May 26, 2022 1 $0 4 May 31, 2022 Director
SWTX SpringWorks Therapeutics, Inc. Jan 7, 2022 1 -$224K 4/A Jan 14, 2022 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Jan 6, 2022 2 $0 4 Jan 10, 2022 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Oct 20, 2021 1 -$592K 4 Oct 20, 2021 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Oct 18, 2021 2 -$3.07M 4 Oct 19, 2021 Chief Executive Officer, Director
SWTX SpringWorks Therapeutics, Inc. Jul 19, 2021 2 -$4.79M 4 Jul 20, 2021 Chief Executive Officer, Director
SPRY Silverback Therapeutics, Inc. Jun 4, 2021 1 $0 4 Sep 21, 2021 Director
PASG Passage BIO, Inc. May 27, 2021 1 $0 4 May 28, 2021 Director